Reducing pathology in Alzheimer’s Disease through Angiotensin targeting (RADAR)
This study aims to investigate whether a commonly used drug losartan that is normally used to treat people with high blood pressure, can help slow down damage to brain tissue and as a result slow the progression of AD. Previous research indicates that losartan could be helpful in this way but as yet no conclusive results, such as in a clinical trial, have been produced.
We are inviting people who have received a diagnosis of Alzheimer’s Disease, over the age of 55.
This research study can also be found on the Join Dementia Research website www.joindementiaresearch.nihr.ac.uk
For more information on the Clinical Research Network Profile visit public.ukcrn.org.uk